Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

Comparison of Medication Practices in Patients With Heart Failure and Preserved Versus Those With Reduced Ejection Fraction (from the Cardiovascular Research Network [CVRN])

(2013) Robert J. Goldberg et al.   AMERICAN JOURNAL OF CARDIOLOGY

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

(2013) F. P. Brouwers et al.   EUROPEAN HEART JOURNAL

Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

(2013) Frank Edelmann et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

(2013) Margaret M. Redfield et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Defining Diastolic Heart Failure and Identifying Effective Therapies

(2013) John G. F. Cleland et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

BLOOD HYPEROSMOLARITY AS A PREDICTOR OF MORTALITY IN PATIENTS AFTER ACUTE CORONARY SYNDROME: HOW DEHYDRATION AFFECTS THE PROGNOSIS OF OUR PATIENTS

(2013) Sem Briongos-Figuero et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Design of the RELAXin in Acute Heart Failure Study

(2012) Piotr Ponikowski et al.   AMERICAN HEART JOURNAL

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

(2012) Kalkidan Bishu et al.   AMERICAN HEART JOURNAL

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

(2012) James L. Januzzi et al.   EUROPEAN HEART JOURNAL

The role of the kidney in heart failure

(2012) M. Metra et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial

(2012) Andrew P. Ambrosy et al.   EUROPEAN JOURNAL OF HEART FAILURE

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

(2012) John R Teerlink et al.   LANCET

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

(2011)   EUROPEAN HEART JOURNAL

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

(2011) C.M. O'Connor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Troponin Elevation in Heart Failure

(2010) Robb D. Kociol et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

(2010) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

State of the art: Using natriuretic peptide levels in clinical practice

(2008) Alan Maisel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure

(2008) Dimitrios Farmakis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE